Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emilie Varey

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Cold Spring Harbor Perspectives in Medicine|November 5, 2013
Effector mechanisms of rejectionAurélie Moreau, Emilie Varey, Ignacio Anegon, et al.
Transplantation Research|February 2, 2013
Cell therapy using tolerogenic dendritic cells in transplantationAurélie Moreau, Emilie Varey, Laurence Bouchet-Delbos, et al.
Cancers|October 13, 2021
Severe Late-Onset Grade III-IV Adverse Events under Immunotherapy: A Retrospective Study of 79 CasesJean-Matthieu L'Orphelin, Emilie Varey, Amir Khammari, et al.
Dermatology (Basel, Switzerland)|November 24, 2021
Should Targeted Therapy Be Continued in BRAF-Mutant Melanoma Patients after Complete Remission?Eve Bédouelle, Jean Michel Nguyen, Emilie Varey, et al.
European Journal of Dermatology : EJD|July 11, 2023
Machine learning algorithm to predict response to immunotherapy in real-life settings for patients with advanced melanomaCécile Frenard, Katleen Blanchet, Philippe Lecerf, et al.
European Journal of Dermatology : EJD|April 5, 2021
Cardiac adverse events associated with anti-PD-1 therapy in patients treated for advanced melanoma: relevance of dosing troponin T levelsCamille Scard, Jean-Michel Nguyen, Emilie Varey, et al.
European Journal of Dermatology : EJD|July 11, 2023
Panniculitis does not predict clinical response in patients with advanced melanoma under targeted therapyMarie Piroth, Thomas Goronflot, Romain Samaran, et al.
Medicine|July 25, 2020
Chemotherapy efficacy after first-line immunotherapy in 18 advanced melanoma patientsMélanie Saint-Jean, Clémentine Fronteau, Lucie Peuvrel, et al.
Frontiers in Immunology|August 22, 2012
Tolerogenic dendritic cells and negative vaccination in transplantation: from rodents to clinical trialsAurélie Moreau, Emilie Varey, Gaëlle Bériou, et al.
European Journal of Dermatology : EJD|November 1, 2018
Positive margins after surgical excision of locoregional cutaneous melanoma metastasis and their impact on patient outcomeBarbara Bregeon, Jean-Michel Nguyen, Emilie Varey, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Cold Spring Harbor Perspectives in Medicine|November 5, 2013
Effector mechanisms of rejectionAurélie Moreau, Emilie Varey, Ignacio Anegon, et al.
Transplantation Research|February 2, 2013
Cell therapy using tolerogenic dendritic cells in transplantationAurélie Moreau, Emilie Varey, Laurence Bouchet-Delbos, et al.
Cancers|October 13, 2021
Severe Late-Onset Grade III-IV Adverse Events under Immunotherapy: A Retrospective Study of 79 CasesJean-Matthieu L'Orphelin, Emilie Varey, Amir Khammari, et al.
Dermatology (Basel, Switzerland)|November 24, 2021
Should Targeted Therapy Be Continued in BRAF-Mutant Melanoma Patients after Complete Remission?Eve Bédouelle, Jean Michel Nguyen, Emilie Varey, et al.
European Journal of Dermatology : EJD|July 11, 2023
Machine learning algorithm to predict response to immunotherapy in real-life settings for patients with advanced melanomaCécile Frenard, Katleen Blanchet, Philippe Lecerf, et al.
European Journal of Dermatology : EJD|April 5, 2021
Cardiac adverse events associated with anti-PD-1 therapy in patients treated for advanced melanoma: relevance of dosing troponin T levelsCamille Scard, Jean-Michel Nguyen, Emilie Varey, et al.
European Journal of Dermatology : EJD|July 11, 2023
Panniculitis does not predict clinical response in patients with advanced melanoma under targeted therapyMarie Piroth, Thomas Goronflot, Romain Samaran, et al.
Medicine|July 25, 2020
Chemotherapy efficacy after first-line immunotherapy in 18 advanced melanoma patientsMélanie Saint-Jean, Clémentine Fronteau, Lucie Peuvrel, et al.
Frontiers in Immunology|August 22, 2012
Tolerogenic dendritic cells and negative vaccination in transplantation: from rodents to clinical trialsAurélie Moreau, Emilie Varey, Gaëlle Bériou, et al.
European Journal of Dermatology : EJD|November 1, 2018
Positive margins after surgical excision of locoregional cutaneous melanoma metastasis and their impact on patient outcomeBarbara Bregeon, Jean-Michel Nguyen, Emilie Varey, et al.
Pageof 3